144 related articles for article (PubMed ID: 21297268)
1. CDR state transition probabilities in Alzheimer's disease with and without cholinesterase inhibitor intervention in an observational cohort.
Bloudek LM; Spackman DE; Veenstra DL; Sullivan SD
J Alzheimers Dis; 2011; 24(3):599-607. PubMed ID: 21297268
[TBL] [Abstract][Full Text] [Related]
2. Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease.
Zhu CW; Livote EE; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
Alzheimers Dement; 2013 Nov; 9(6):733-40. PubMed ID: 23332671
[TBL] [Abstract][Full Text] [Related]
3. Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.
Mielke MM; Leoutsakos JM; Corcoran CD; Green RC; Norton MC; Welsh-Bohmer KA; Tschanz JT; Lyketsos CG
Alzheimers Demen
